Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar 16;12(3):e0172602.
doi: 10.1371/journal.pone.0172602. eCollection 2017.

Obstetrician's risk perception on the prescription of magnesium sulfate in severe preeclampsia and eclampsia: A qualitative study in Brazil

Fátima Aparecida Lotufo  1 , Mary Angela Parpinelli  1 , Maria José Osis  2 , Fernanda Garanhani Surita  1 , Maria Laura Costa  1 , José Guilherme Cecatti  1
Affiliations

Obstetrician's risk perception on the prescription of magnesium sulfate in severe preeclampsia and eclampsia: A qualitative study in Brazil

Fátima Aparecida Lotufo et al. PLoS One. .

Abstract

Introduction: Magnesium sulfate (MgSO4) is the drug of choice for the prevention and control of seizures in the management of severe preeclampsia/eclampsia. Several barriers have been identified in the use of MgSO4, especially in low and middle-income settings.

Objective: To describe the obstetrician's perception on possible reasons for underutilizing magnesium sulfate to treat preeclampsia/eclampsia.

Method: A qualitative clinical study, based on phenomenological reference by semi-structured interviews and open-ended discussions with obstetricians of the public healthcare system in primary care units (PCU) and referral maternity hospitals (RMH), in a southeastern Brazilian city.

Results: Fear of drug toxicity was the major cause for not prescribing the medication in PCU. Fear was justified by insufficient technical, structural and organizational resources of healthcare facilities and by a shortage of physicians properly trained for adequate drug use.

Conclusion: Fear of toxicity of magnesium sulfate was the main barrier towards timely and proper drug use. Periodic skill development and training of obstetricians, along with integration of the medical team in the work environment may contribute to decrease fear, ensuring safety of drug prescription and thus possibly reducing adverse outcomes related to PE.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Process of category construction.
See this image and copyright information in PMC

References

    1. World Health Organization. Global Health Observatory (GHO) data. Maternal and Reproductive Health. Available at http://www.who.int/gho/maternal_health/en/ Access on Feb 20th 2016.
    1. Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013; 170(1):1–7. 10.1016/j.ejogrb.2013.05.005 - DOI - PubMed
    1. Brazil. Ministry of Health. Department of Informatics. Health information. Vital Statistics—mortality and live births in 2013. Available at http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sim/cnv/mat10uf.def Access on Jan 26th 2016.
    1. The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet. 1995; 345 (8963):1455–63. - PubMed
    1. The Magpie Trail Collaborate Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulfate? The Magpie Trail: a randomised placebo-controlled trial. Lancet 2002; 359: 1877–90. - PubMed

Substances

LinkOut - more resources